RSS

Abbott

The FDA has approved the world’s smallest mechanical heart valve designed for mitral or aortic valve replacement in babies and toddlers. more

News

Heart failure patients at Brigham and Women’s Hospital had lower rates of blood clots and strokes thanks to a new medical device, findings show. more

Devices

With a growing demand for medical technologies all over the world and reports that markets in the east are expected to grow, MPN takes a look at what potential the Irish medtech sector has in the Middle East. more

Opinion

MPN takes a look at some the biggest medical device recalls that have taken place over the recent years. more

Devices

In the latest edition of Medical Plastics News, group editor Lu Rahman discusses issues of data security and whether we should trust connected medical devices. more

Opinion

Healthcare company Abbott has announced that its FreeStyle Libre sensor is now available on prescription in England, Wales, Northern Ireland & Scotland. more

Devices

In a move that’s sure to please adults with diabetes in the US, the FDA has approved a glucose monitoring device that doesn’t require the user to prick themselves for a blood sample. more

Devices

A number of medical manufacturers based in Puerto Rico have responded to the impact and damage caused by hurricane Maria. more

News

A system designed to automatically measure glucose levels through a sensor has been approved by the NHS and will be available for reimbursement across England, Wales, Scotland and Northern Ireland from 1 November. more

News

Medical Plastics News takes a look at some of the biggest stories that have emerged over the past week. more

News

Over 500,000 pacemakers developed by medical device maker Abbott have been shown to contain cyber-security issues. more

Devices

Healthcare company Abbott has announced that its smartphone compatible Confirm Insertable Cardiac Monitor (ICM) has gained CE Mark approval. more

Devices

The Food and Drug Administration (FDA) has warned medical device maker Abbott that it must submit a plan to address any cybersecurity issues and other safety issues identified in cardiac devices from the company’s recently acquired St Jude Medical. more

News

Abbott is aiming to recruit more than 150 people to work at its UK diabetes care manufacturing hub in Witney, Oxfordshire more

News

The US Food and Drug Administration (FDA) Advisory Committee gives Abbott’s fully dissolving heart stent a positive review and recommends the FDA approve it more

News

A drug-eluting coronary stent made of a biodegradable polymer performed similarly to the gold-standard metal one in a non-inferiority trial among patients with the more serious type of heart attack known as ST-segment elevation myocardial infarction more

News

Abbott has announced positive one-year clinical results from the Absorb III trial more

News

Diabetes Professional Care 2015 will take place at the Barbican Exhibition Centre in London from 11-12 November more

News

Done deal: Abbott has completed its acquisition of Topera, a medical device company focused on developing innovative electrophysiology technologies more

News

In the lead: The growing market for glucose monitoring devices in Benelux and Scandinavian countries is currently led by Roche more

News